Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
(OCT IOL Trial)
Trial Summary
What is the purpose of this trial?
The long-term goal of this project is to utilize very high-speed optical coherence tomography (OCT) technology to guide surgical treatments of corneal diseases. OCT is well known for its exquisite resolution, but until recently it has not had sufficient speed to capture the shape of the cornea because of eye motion during OCT scanning. The development of Fourier-domain (FD) OCT technology has made the requisite speed possible. The objective of this project is to develop methods for imaging the cornea with an FD-OCT system that will precisely measure corneal shape and use this information to guide surgery. Cataract surgery in patients with previous laser vision correction often leads to significant near- or far-sightedness, a problem that could be resolved by using a more accurate intraocular lens power selection formula based on the measurement of corneal refractive power with OCT.
Research Team
David Huang, MD, PhD
Principal Investigator
Casey Eye Institute, Oregon Health & Science University
Eligibility Criteria
Inclusion Criteria
Treatment Details
Interventions
- Cataract Surgery (Procedure)
- Optical Coherence Tomography (Diagnostic Test)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor
John Hunter
Oregon Health and Science University
Chief Medical Officer since 2024
MD, specific details unavailable
Ann Madden Rice
Oregon Health and Science University
Chief Executive Officer
FACHE certification, extensive leadership experience in academic health centers
National Eye Institute (NEI)
Collaborator
Dr. Michael F. Chiang
National Eye Institute (NEI)
Chief Executive Officer since 2020
MD from Harvard Medical School
Dr. Richard Lee
National Eye Institute (NEI)
Chief Medical Officer since 2021
MD, PhD from Harvard Medical School